Meriscreen covid 19 antigen

MeriScreen Antigen Test

Principo

COVID-19 Antigen Detection Test estas imunanaliza testo por rapida kaj kvalita detekto de SARS-CoV-2-infekto de vatbaj specimenoj. Unuklonaj kontraŭ-SARS-CoV-2 antikorpoj estas kovritaj sur la provlinia regiono. Antigenoj de SARS-CoV-2, se ĉeestas en la specimenoj, interagos kun unuklonaj kontraŭSARS-CoV-2-antikorpoj konjugaciitaj kun ora konjugato faranta kombinaĵon de antigeno-antikorpoj konjugita. Ĉi tiu komplekso migras sur la membrano per kapilara ago, kie ĝi estos kaptita de la unuklona kontraŭ-SARS-CoV-2 antikorpo kovrita sur la testlinio. Kolora testlinio estus videbla en la rezultfenestro se SARS-CoV-2-antigenoj ĉeestas en la specimeno. La intenseco de kolora testlinio varias dependi de la kvanto de SARS-CoV-2-antigeno ĉeestanta en la specimeno.

SKU: NCTCAG-01

DISPONIBLE: Elĉerpita

SENDO: 1 aŭ 2 Labortagoj senpage

GRANDO: 25 Testoj / Ilaro

SENTIVECO: 96,6%

SPECIFO: 100%

 

 

meriscreen-covid-19-antigen-test-kit-pack
meriscreen-covid-19-antigen-test-kit-pack

MERISCREEN COVID-19 ANTIGENA TESTO-KITO

MeriScreen COVID-19 Antigen Detection Test estas rapida imunokromatografia analiza testo por la kvalita detekto de SARS-CoV-2-antigeno en nazofaringea vatbotabelo de homa korpo.

  • Kovrita per tre purigita monoklona kontraŭ-SARS-COV-2-antikorpo
  • REZULTOJ EN 20 MINUTOJ
  • EKZEMPLO ESTAS NAZOFARINGA VARBO
  • SENTIVECO: 96,6%
  • SPECIFO: 100%

Bonvolu Noti:
 Sub listigitaj ilaroj validas nur kun la menciita aro-numero. Respondeco pri
intera konsisto ne kuŝas ĉe ICMR.
 Minimumaj akceptaj kriterioj de sentemo kaj specifeco de Rapid Ag Test Testoj:
 Validigita kiel Punkto de Prizorga Testo (POCT) sen transporto al laboratorio-aranĝo Sentemo: 50% kaj pli
Specifeco: 95% kaj pli
 Validigita en laboratorio-aranĝo kun specimenoj kolektita en Virus Transport Medium (VTM) –
Sentemo: 70% kaj pli
Specifeco: 99% kaj pli
 Antigenaj bazaj rapidaj testoj aprobitaj de Usono-FDA povas esti uzataj rekte post konvena merkatiga aprobo de DCGI.

 

meriscreen-covid-19-antigen-test-kit
meriscreen-covid-19-antigen-test-kit

Mallonga metodiko pri uzo de COVID-19 Ag Respi-Strip (CorisBioConcept):
1. La nazofaringea kaj / aŭ orofaringea vatado estos kolektita de COVID-19-suspektata paciento en Virus Transport Medium (VTM).
2. La kolektita vatbulo en VTM estos alportita al la laboratorio en taŭgaj kondiĉoj de malvarma ĉeno.
3. Post kiam la specimeno estos alportita al la laboratorio, ĝi devos esti pritraktita en BSL-2-nivela ŝranko por alikvotado, enmetado de liza bufro kaj ŝarĝo de la testostrio.
 Paŝoj 1 kaj 2 plenumiĝos laŭ la norma praktiko sekvita por kolekto kaj transporto de specimenoj por COVID-19 RT-PCR-testo.
 Paŝo 3 devos esti plenumita laŭ la instrukcioj de fabrikantoj donitaj kun la testkompleto.

 

Facile uzebla

Uzantamika interfaco; Postulas neniun specialan kompetentecon aŭ vastan trejnadon.

Alta Precizeco kaj Fidindeco

Bonega sentemo kaj specifeco kompare kun molekulaj kaj virusaj kulturaj metodoj.

Oportunaj Stokaj Elektoj

Malgranda instrumento kaj ĉambro-tempa stokado taŭga por iu ajn oficejo aŭ laboratorio.

Reduktitaj Eraroj de Uzanto

QR-koda skanado aŭtomate identigas la testospecon

Duopaj Testaj Elektoj

Duopaj testaj ebloj permesas pli grandan testan flekseblecon

 

 

CA199 (Cancer antigen) ELISA test

13 96T/Box Ask for price
  • Area of application: Hormone testing
Description: ELISA based test for quantitative detection of CA199 (Cancer antigen)

CA153 (Cancer antigen) ELISA test

12 96T/Box Ask for price
  • Area of application: Hormone testing
Description: ELISA based test for quantitative detection of CA153 (Cancer antigen)

CA50 (Cancer antigen) ELISA test

10 96T/Box Ask for price
  • Area of application: Hormone testing
Description: ELISA based test for quantitative detection of CA50 (Cancer antigen)

CEA (Cancer antigen) ELISA test

9 96T/Box Ask for price
  • Area of application: Hormone testing
Description: ELISA based test for quantitative detection of CEA (Cancer antigen)

PSA (Prostate-specific antigen) ELISA test

8 96T/Box Ask for price
  • Area of application: Hormone testing
Description: ELISA based test for quantitative detection of PSA (Prostate-specific antigen)

HBsAg hepatitis B surface antigen ELISA test

77 96T/Box Ask for price
  • Area of application: Hepatitis testing
Description: ELISA based test for quantitative detection of HBsAg hepatitis B surface antigen

HBeAg hepatitis B E antigen ELISA test

79 96T/Box Ask for price
  • Area of application: Hepatitis testing
Description: ELISA based test for quantitative detection of HBeAg hepatitis B E antigen

HEV-Ag hepatitis E antigen ELISA test

94 96T/Box Ask for price
  • Area of application: Hepatitis testing
Description: ELISA based test for quantitative detection of HEV-Ag hepatitis E antigen

SARS-CoV-2 Antigen Rapid Test Kit

CoV2Ag-1 1T
EUR 8
  • when the Ct value ≤ 37 the sensitivity was 94.483% (95%CI: 89.418%, 97.588%) and specificity was 99.327% (95%CI: 97.589%, 99.918%). when the Ct value ≤ 30 the sensitivity was 96.330% (95%CI: 90.870%, 98.991%) and specificity was 99.327% (95%CI: 9
  • Show more
Description: This kit adopts the sandwich method and the technical principle of colloidal gold immunochromatography to qualitative determine the SARS-CoV-2 antigen. During the test, the sample is dropped into the sample well, and chromatography is performed under the capillary effect. The SARS-CoV-2 antigen in the sample combined with the colloidal goldlabeled SARS-CoV-2 monoclonal antibody I, and then spread to the test area. It is captured by another coated antibody (SARS-CoV-2 monoclonal antibody II), to form a complex and gather in the test area (T line). The quality control area is coated with the goat antimouse antibody, and the colloidal gold-labeled antibody is captured to form a complex and aggregate in the quality control area (C line). If the C line does not show color, it indicates that the result is invalid, and this sample needs to be tested again.

SARS-CoV-2 Antigen Rapid Test Kit

CoV2Ag-25 25T/kit
EUR 35
  • Relative sensitivity: 96.17 %
  • Relative specificity: >99.9%
  • Accuracy:98.79%%
  • Specimen: Saliva, 10-20 minutes to get results
Description: This product is used for in vitro qualitative detection of SARS-CoV-2 antigen in human oropharyngeal swabs, nasal swabs and nasopharyngeal swabs. It is helpful as an aid in the screening of early mild, asymptomatic, or acute patients for identification of SARS-CoV-2 infection.

SARS-CoV-2 Rapid Antigen Test Nasal

9901-NCOV-03G 25 Tests/Kit
EUR 94
  • Test type: Qualitative
  • Sample type: Nasal swab
  • Target antigen: Nucleocapsid (N)
  • Time to result: 15 minutes (Readout window 15 - 30 minutes)
  • Stability (test, opened pouch): 1 hour once the test has been opened
Description: The SARS-CoV-2 Rapid Antigen Test is a lateral fl ow rapid chromatographic immunoassay for the qualitative detection of nucleocapsid antigen to SARS-CoV-2 present in human nasal samples. This test is intended for use as an aid in detection of SARS-CoV-2 infection in individuals suspected of COVID-19 with clinical symptoms onset within 5 days. Results are for the identification of SARS-CoV-2 nucleocapsid antigen. Antigen is generally detectable in human nasal swab samples during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Positive results do not rule out bacterial infection or co- infection with other viruses. The agent detected may not be the definite cause of disease. Negative results should be treated as presumptive, and do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. Negative results should be considered in the context of a patient’s recent exposures, history and the presence of clinical signs and symptoms consistent with COVID-19, and confirmed with a molecular assay, if necessary, for patient management. The SARS-CoV-2 Rapid Antigen Test is intended for use in laboratory or POC settings by healthcare professionals, or self-collection under the supervision of a healthcare worke

Human Streptococcus Pneumoniae (SP) Antigen Rapid Test Kit

abx092096-20tests 20 tests
EUR 398
  • Shipped within 5-12 working days.

Accu-Tell COVID-19 IgG/IgM Rapid Test

GEN-B352-20tests 20 tests
EUR 236
Description: A rapid test for detection of antibodies (IgG and IgM) for 2019-nCoV, the novel Coronavirus from the Wuhan strain. The test is easy to perform, takes 10 minutes to provide reliable results and is higly specific to the 2019-nCoV Coronavirus.

Accu-Tell COVID-19 IgG/IgM Rapid Test

GEN-B352-40tests 40 tests
EUR 321
Description: A rapid test for detection of antibodies (IgG and IgM) for 2019-nCoV, the novel Coronavirus from the Wuhan strain. The test is easy to perform, takes 10 minutes to provide reliable results and is higly specific to the 2019-nCoV Coronavirus.

Avian Influenza Virus Antigen Rapid Test Kit (Colloidal gold)

abx092015-40tests 40 tests
EUR 432
  • Shipped within 5-12 working days.

Newcastle Disease Virus Antigen Rapid Test Kit (Colloidal gold)

abx092016-40tests 40 tests
EUR 432
  • Shipped within 5-12 working days.

Human Chlamydia Trachomatis Antigen Rapid Test Kit (Colloidal gold)

abx092049-20tests 20 tests
EUR 230
  • Shipped within 5-12 working days.

Coronavirus (SARS-Cov-2) Antigen Rapid Test Device (Saliva)

IOV87952 20T/kit
EUR 39
Description: Coronavirus (SARS-Cov-2) Antigen Rapid Test Device (Saliva) is an in vitro diagnostic test for the qualitative detection of novel coronavirus antigens in human saliva, using the rapid immunochromatographic method. The identification is based on the monoclonal antibodies specific for the novel coronvirus antigen. It will provide information for clinical doctors to prescribe correct medications.

Avian Influenza H5 Virus Antigen Rapid Test Kit (Colloidal gold)

abx092014-40tests 40 tests
EUR 488
  • Shipped within 5-12 working days.

Leave a Comment

Your email address will not be published. Required fields are marked *